FIELD: pharmacology.
SUBSTANCE: group of inventions refers to a method for obesity development treatment or inhibition, comprising administration of a therapeutically effective amount of a compound or a pharmaceutically acceptable salt thereof of the following general formula:
,
where R1 and R2 are hydroxy, G is -CH3, R3 piperidinyl, to the subject in need of such treatment or inhibition; as well as to methods for such treatment by administering the said compound in combination with estrogen or dehydroepiandrosterone.
EFFECT: increased efficiency of treatment.
8 cl, 13 tbl, 13 ex, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING AND/OR SUPPRESSING WEIGHT GROWTH | 2000 |
|
RU2519642C2 |
| METHOD OF MASS INCREASE TREATMENT AND/OR INHIITION | 2000 |
|
RU2327461C2 |
| MEDICAL APPLICATIONS SELECTIVE ESTROGEN RECEPTOR MODULATORS IN COMBINATION WITH STEROID SEX HORMONE PRECURSORS | 1999 |
|
RU2246947C2 |
| COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING MENOPAUSAL SYNDROME IN FEMALES, CONTAINING LOGANIN OR DERIVATIVES THEREOF AS AN ACTIVE INGREDIENT | 2017 |
|
RU2697672C1 |
| PARATHYROID HORMONE ANALOGUES FOR OSTEOPOROSIS TREATMENT | 1997 |
|
RU2203286C2 |
| APPLICATION OF SOPHORICOSIDE FOR PREPARING DRUGS | 2009 |
|
RU2454236C1 |
| APPLICATION OF HESPERIDINE OR ONE OF ITS DERIVATIVES FOR MANUFACTURING MEDICINAL PREPARATION INDICATED FOR OSTEOGENESIS STIMULATION | 2003 |
|
RU2320346C2 |
| SARM COMPOUNDS AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2571421C2 |
| 7-HYDROXYEPIANDROSTERON WITH NEUROPROTECTIVE ACTIVITY | 2001 |
|
RU2307654C2 |
| APPLICATION OF NUTRITIVE COMPOSITIONS FOR DISEASES PREVENTION | 2007 |
|
RU2444912C2 |
